Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

被引：24
作者：
Bansal, Amar D. [1 ]
Hill, Chloe E. [2 ]
Berns, Jeffrey S. [1 ]
机构：
[1] Univ Penn, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
SEMINARS IN DIALYSIS | 2015年 / 28卷 / 04期
关键词：
GRANULOMATOUS INTERSTITIAL NEPHRITIS; ANTIDIURETIC-HORMONE SECRETION; HIGH-FLUX HEMODIALYSIS; PROTEIN-BINDING; PERITONEAL-DIALYSIS; PHARMACOKINETICS; CARBAMAZEPINE; LAMOTRIGINE; TOPIRAMATE; GABAPENTIN;
D O I：
10.1111/sdi.12385
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Epilepsy is a disorder with an approximate worldwide prevalence of 1%. Due to complexities of metabolism, protein-binding, renal elimination, and other pharmacokinetic parameters, the dosing of antiepileptic drugs (AEDs) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD) deserves special attention. This is a review of the most commonly prescribed AEDs with special focus on their indication, pharmacokinetics, and unique considerations for use in patients with CKD and ESRD. A review of their renal toxicities is also included.
引用
收藏
页码：404 / 412
页数：9
相关论文
共 50 条
  • [31] Opioid Safety and Concomitant Benzodiazepine Use in End-Stage Renal Disease Patients
    Ruchi, Rupam
    Bozorgmehri, Shahab
    Ozrazgat-Baslanti, Tezcan
    Segal, Mark S.
    Shukla, Ashutosh M.
    Mohandas, Rajesh
    Kumar, Sanjeev
    PAIN RESEARCH & MANAGEMENT, 2019, 2019
  • [32] Obesity Paradox in End-Stage Kidney Disease Patients
    Park, Jongha
    Ahmadi, Seyed-Foad
    Streja, Elani
    Molnar, Miklos Z.
    Flegar, Katherine M.
    Gillen, Daniel
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    PROGRESS IN CARDIOVASCULAR DISEASES, 2014, 56 (04) : 415 - 425
  • [33] Management of Elderly Patients With End-Stage Kidney Disease
    Dimkovic, Nada
    Oreopoulos, Dimitrios
    SEMINARS IN NEPHROLOGY, 2009, 29 (06) : 643 - 649
  • [34] Management of pain in end-stage renal disease patients: Short review
    Raina, Rupesh
    Krishnappa, Vinod
    Gupta, Mona
    HEMODIALYSIS INTERNATIONAL, 2018, 22 (03) : 290 - 296
  • [35] Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis
    Bibi, Guy
    Green, Yaakov
    Nagler, Rafael M.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (02) : 164 - 170
  • [36] Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?
    Martin, William P.
    White, James
    Lopez-Hernandez, Francisco J.
    Docherty, Neil G.
    le Roux, Carel W.
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [37] Pharmacokinetics of rosiglitazone in patients with end-stage renal disease
    Thompson-Culkin, K
    Zussman, B
    Miller, AK
    Freed, MI
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2002, 30 (04) : 391 - 399
  • [38] Apolipoproteins A and B and PCSK9: Nontraditional Cardiovascular Risk Factors in Chronic Kidney Disease and in End-Stage Renal Disease
    Vlad, Cristiana-Elena
    Foia, Liliana
    Popescu, Roxana
    Ivanov, Iuliu
    Luca, Mihaela Catalina
    Delianu, Carmen
    Toma, Vasilica
    Statescu, Cristian
    Rezus, Ciprian
    Florea, Laura
    JOURNAL OF DIABETES RESEARCH, 2019, 2019
  • [39] Antidiabetic Therapy in End-Stage Renal Disease
    Boyle, Suzanne M.
    Simon, Barbara
    Kobrin, Sidney M.
    SEMINARS IN DIALYSIS, 2015, 28 (04) : 337 - 344
  • [40] Influenza and the patient with end-stage renal disease
    Bowman, Brendan T.
    Rosner, Mitchell H.
    JOURNAL OF NEPHROLOGY, 2018, 31 (02) : 225 - 230
12345